MedTrace Logo

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

NCT03841396 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-02-15

No results posted yet for this study

Summary

A Phase IV, Randomised, Double-blind, Single-centre clinical trial in healthy male and female participants aged 18 to 55, that was designed to assess and compare the pain intensity at an injection site as well as the duration of pain following a single dose subcutaneous administration of two low molecular weight heparins (LMWH) respectively.

Conditions

  • Injection Site Reaction

Interventions

DRUG

Sodium chloride

All participants received a single dose of sodium chloride as placebo

Sponsors & Collaborators

  • Aspen Global Incorporated

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-02
Primary Completion
2016-07-15
Completion
2016-07-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03841396 on ClinicalTrials.gov